Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations

Four Systemic Lupus Erythematosus Subgroups, Defined by Autoantibodies Status, Differ Regarding HLA‐DRB1 Genotype Associations and Immunological and Clinical Manifestations

Objective The heterogeneity of systemic lupus erythematosus (SLE) constitutes clinical and therapeutical challenges. We therefore studied whether unrecognized disease subgroups can be identified by using autoantibody profiling together with HLA‐DRB1 alleles and immunological and clinical data. Metho...

Full description

Bibliographic Details
Main Authors:	Lina‐Marcela Diaz‐Gallo, Vilija Oke, Emeli Lundström, Kerstin Elvin, Yee Ling Wu, Susanna Eketjäll, Agneta Zickert, Johanna T. Gustafsson, Andreas Jönsen, Dag Leonard, Daniel J. Birmingham, Gunnel Nordmark, Anders A. Bengtsson, Lars Rönnblom, Iva Gunnarsson, Chack‐Yung Yu, Leonid Padyukov, Elisabet Svenungsson
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	ACR Open Rheumatology
Online Access:	https://doi.org/10.1002/acr2.11343

Similar Items

High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus
by: Vilija Oke, et al.
Published: (2019-04-01)

O10 Ischemic stroke subtypes in SLE-associations with a STAT4 risk genotype
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
by: Vilija Oke, et al.
Published: (2017-06-01)

Interleukin (IL) 16: a candidate urinary biomarker for proliferative lupus nephritis
by: Anders Larsson, et al.
Published: (2022-07-01)

S13.2 Anti-phosphatidylserine/prothrombin antibodies and thrombosis associate positively with hHLA-DRB1 *13 and negatively with HLA-DRB1*03 in SLE
by: J Rönnelid, et al.
Published: (2022-10-01)

Sex differences in clinical presentation of systemic lupus erythematosus
by: Jorge I. Ramírez Sepúlveda, et al.
Published: (2019-12-01)

Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus
by: Ioannis Parodis, et al.
Published: (2020-05-01)

O34 Plasma thrombospondin-1 levels are associated with arterial and venous thrombotic events in systemic lupus erythematosus
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

P58 Menopausal age and the effect of menopause on disease activity in SLE
by: Aleksandra Antovic, et al.
Published: (2024-03-01)

O12 Immune complexes containing anti-dsDNA in patients with systemic lupus erythematosus with renal involvement – Association with renal activity and response to treatment
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

P10 IL-16 expression in kidney biopsies from patients with SLE- and antiphosholipid syndrome- associated renal thrombotic microangiopathy and renal IgA vasculitis
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

Novel risk genes for systemic lupus erythematosus predicted by random forest classification
by: Jonas Carlsson Almlöf, et al.
Published: (2017-07-01)

PO.1.20 Prognostic biomarkers of organ damage in patients with newly diagnosed SLE
by: D Leonard, et al.
Published: (2022-10-01)

Antiphospholipid Antibodies in Lupus Nephritis.
by: Ioannis Parodis, et al.
Published: (2016-01-01)

P145 Circulating interferon-α levels are elevated during pregnancy in women with SLE who deliver infants that are small for gestational age, preterm and/or have low birth weight
by: Henrik Zetterberg, et al.
Published: (2024-03-01)

P146 Low CD4+ T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy
by: Henrik Zetterberg, et al.
Published: (2024-03-01)

Low CD4 + T cell count is related to specific anti-nuclear antibodies, IFNα protein positivity and disease activity in systemic lupus erythematosus pregnancy
by: Agnes Torell, et al.
Published: (2024-03-01)

Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus
by: Agnes Torell, et al.
Published: (2023-06-01)

Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness
by: Filip Segerberg, et al.
Published: (2019-09-01)

LP-016 Anti-histone and anti-nucleosome antibodies, rather than anti-dsDNA antibodies are associated with interferon-induced biomarkers in Sudanese and Swedish SLE patients
by: Anders Larsson, et al.
Published: (2023-07-01)

S12.1 Il-16 – a urinary biomarker for proliferative lupus nephritis
by: V Oke, et al.
Published: (2022-10-01)

Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus
by: Azita Sohrabian, et al.
Published: (2019-11-01)

HLA-DRB1 allele and autoantibody profiles in Japanese patients with inclusion body myositis.
by: Munenori Oyama, et al.
Published: (2020-01-01)

P130 Patients’ thoughts of triggers for lupus onset and flares
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)

S10.2 Interaction between HLA-DRB1*03:01 and stat4 is associated with increased risk of nephritis in systemic lupus erythematosus
by: S Reid, et al.
Published: (2022-10-01)

Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
by: Johanna T Gustafsson, et al.
Published: (2017-01-01)

A research study of the association between maternal microchimerism and systemic lupus erythematosus in adults: a comparison between patients and healthy controls based on single-nucleotide polymorphism using quantitative real-time PCR.
by: Anna Maria Jonsson Kanold, et al.
Published: (2013-01-01)

DNA Methylation-Based Interferon Scores Associate With Sub-Phenotypes in Primary Sjögren’s Syndrome
by: Juliana Imgenberg-Kreuz, et al.
Published: (2021-07-01)

Effects of GSTM1 in rheumatoid arthritis; results from the Swedish EIRA study.
by: Emeli Lundström, et al.
Published: (2011-01-01)

HLA-DRB1 and month of birth in multiple sclerosis.
by: Ramagopalan, S, et al.
Published: (2009)

Association of human leukocyte antigen-DRB1 with anti-cyclic citrullinated peptide autoantibodies in Saudi patients with rheumatoid arthritis
by: Abdullah Alrogy, et al.
Published: (2017-01-01)

HLA-DRB1 and HLA-DQB1 Are Associated with Adult-Onset Immunodeficiency with Acquired Anti-Interferon-Gamma Autoantibodies.
by: Manop Pithukpakorn, et al.
Published: (2015-01-01)

Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients
by: Myriam Martin, et al.
Published: (2020-10-01)

ANNUAL REPORT DRB-HICOM : SUSTAINABILITY REPORT DRB-HICOM/
by: DRB-HICOM Berhad 326
Published: (2019)

O30 Anti-histone and anti-nucleosome rather than anti-dsDNA antibodies associate with IFN-induced biomarkers in Sudanese and Swedish SLE patients
by: Anders Larsson, et al.
Published: (2024-03-01)

A spectrum of susceptibility to rheumatoid arthritis within HLA-DRB1: stratification by autoantibody status in a large UK population.
by: Mackie, S, et al.
Published: (2012)

RE: Association of human leukocyte antigen-DRB1 with anti-cyclic citrullinated peptide autoantibodies in Saudi patients with rheumatoid arthritis
by: Marwan Hmoud Adwan
Published: (2017-07-01)

Reevaluation of the interaction between HLA-DRB1 shared epitope alleles, PTPN22, and smoking in determining susceptibility to autoantibody-positive and autoantibody-negative rheumatoid arthritis in a large UK Caucasian population.
by: Morgan, A, et al.
Published: (2009)

Mer-tyrosine kinase: a novel susceptibility gene for SLE related end-stage renal disease
by: Elisabet Svenungsson, et al.
Published: (2022-07-01)

P18 Proteomic analysis of cutaneous lupus erythematosus (CLE) dermal infiltrates and control skin reveals differentially upregulated and downregulated pathways
by: Elisabet Svenungsson, et al.
Published: (2024-03-01)